Renal Cell Carcinoma

Renal cell carcinoma (RCC, also known as hypernephroma) is a kidney cancer that originates in the lining of the proximal convoluted tubule, the very small tubes in the kidney that filter the blood and remove waste products.
What is Renal Cell Carcinoma?

Renal cell carcinoma, also called hypernephroma, is a cancer of the kidneys that forms in the proximal convoluted tubule. In the UK, it is the eighth most common cancer among adults, affecting 9,300 people every year.

Read More

Overview

Feature Articles

Latest Renal Cell Carcinoma News and Research

New AI-powered protein mapping tool optimizes cancer therapy

New AI-powered protein mapping tool optimizes cancer therapy

AI tool maps protein function in tumors, paving way for personalized cancer treatment

AI tool maps protein function in tumors, paving way for personalized cancer treatment

Subcutaneous nivolumab revolutionizes renal cell carcinoma care with faster, easier treatment

Subcutaneous nivolumab revolutionizes renal cell carcinoma care with faster, easier treatment

$2.8M grant targets copper's role in deadly kidney cancer

$2.8M grant targets copper's role in deadly kidney cancer

Pazopanib activity confirmed in EWSR1-NFATC2 bone sarcoma

Pazopanib activity confirmed in EWSR1-NFATC2 bone sarcoma

Study uses game theory to show low tumor heterogeneity leads to higher aggression

Study uses game theory to show low tumor heterogeneity leads to higher aggression

CMA clarifies cooperation on combination therapies to speed up patient access to vital treatments

CMA clarifies cooperation on combination therapies to speed up patient access to vital treatments

HIF-2α inhibitor belzutifan significantly reduces progression of clear cell renal cell carcinoma

HIF-2α inhibitor belzutifan significantly reduces progression of clear cell renal cell carcinoma

Dual-action drug produces shows promising results in neuroendocrine tumor trial

Dual-action drug produces shows promising results in neuroendocrine tumor trial

Everolimus after surgery may benefit patients with very-high-risk clear cell renal cell carcinoma

Everolimus after surgery may benefit patients with very-high-risk clear cell renal cell carcinoma

TTUHSC receives nearly $2.3 million in CPRIT grants to support cancer research

TTUHSC receives nearly $2.3 million in CPRIT grants to support cancer research

Stereotactic radiation therapy offers new hope for older adults with inoperable kidney cancer

Stereotactic radiation therapy offers new hope for older adults with inoperable kidney cancer

AI-based tool can assess pathology slides to identify valuable features of clear cell renal cell carcinoma

AI-based tool can assess pathology slides to identify valuable features of clear cell renal cell carcinoma

Combination of cediranib and lenalidomide does not improve outcomes in advanced thyroid cancer

Combination of cediranib and lenalidomide does not improve outcomes in advanced thyroid cancer

Associations between alcohol intake, cancer risk, and modifying factors in women: smoking, BMI, and MHT interactions

Associations between alcohol intake, cancer risk, and modifying factors in women: smoking, BMI, and MHT interactions

Kidney cancer study reveals new findings about MiTF family gene mutations

Kidney cancer study reveals new findings about MiTF family gene mutations

UCLA researchers confirm mutations that predispose patients to rare kidney cancer syndrome

UCLA researchers confirm mutations that predispose patients to rare kidney cancer syndrome

Fecal transplants safe and effective in treating advanced melanoma, clinical trial shows

Fecal transplants safe and effective in treating advanced melanoma, clinical trial shows

Single-cell RNA sequencing provides new insights into gastric cancer

Single-cell RNA sequencing provides new insights into gastric cancer

New kidney cancer model highlights molecular targets and genomic events that drive metastasis

New kidney cancer model highlights molecular targets and genomic events that drive metastasis